The National Comprehensive Cancer Network (NCCN) Annual Conference was held on March 21-23, 2019 in Orlando, FL. Over 1650 community and academic oncologists, oncology fellows, nurses, pharmacists, and other health care professionals gathered to view and discuss research related to the latest cancer therapies as well as provide updated on selected NCCN Clinical Practice Guidelines in Oncology.
Journal of Clinical Pathways attended the meeting to provide coverage of some of the most pertinent sessions.
Gary H Lyman, MD, MPH, discussed biosimilars in oncology care, providing an overview of what biosimilars are, an update on new developments, and a forecast of how biosimilars may impact cancer costs and treatment.
A session focused on how early experiences of CAR-T therapy delivery have shaped improved processes surrounding the therapy and implications for other innovative agents.
Michelle B Riba, MD, MS, discussed the prevalence of distress in patients with cancer and its potential impact on medical management, as well as strategies for improving integration of psychosocial care into routine care of patients with cancer.
Carlin Callaway, DNP, RN, and Linda Overholser, MD, MPH, discussed the importance of care coordination between primary care providers, oncologists, and other specialists, as well as ways to facilitate enhanced care coordination, including utilization of survivorship care plans.